| Literature DB >> 36227913 |
Abstract
The viscosity, protein, and total aflatoxins contents in orange-fleshed sweetpotato (OFSP) and cereal-based commercial complementary formulations and the effect of dilution on the protein content of the formulations were investigated. Standard procedures were used for the determination of these parameters. Over 80% of the formulations had a viscosity above the recommended consistency of 1000-3000 cP for feeding young children. The consistency of OFSP-legume porridge was significantly (2392.5 cP; p < 0.001) lower, about 1.7 and 3.4 times than cereal-only and cereal-legume blends, respectively. All the complementary flours, except the cereal-only, met the proposed protein requirement of 6 to 11 g per 100 g for feeding children aged 6 to 23 months on an as-is basis. However, the protein content in the porridges on an as-would-be-eaten basis was about 6% lower than the as-is basis value. About 38% of the complementary foods had total aflatoxin level above the acceptable limit of 10 ppb, mainly in blends containing peanuts, maize, or both. Adding more water to meet the required thickness of cereal-only and cereal-legume porridges diluted the protein content. More efforts are needed from regulatory bodies and all stakeholders to ensure complementary foods are safe in terms of mycotoxin levels, particularly those containing maize, peanut, or both as ingredients.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36227913 PMCID: PMC9560132 DOI: 10.1371/journal.pone.0275593
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Moisture and weights taken equivalent to 100 g dry matter content.
| Constituent of complementary food (number of blends) | Moisture as-is (g/100 g) | Weight equivalent to 100 g dry matter content (g) | Total volume of water used to attain suitable viscosity (ml) |
|---|---|---|---|
|
| 3.67 e-g (2.39, 4.95) | 103.81 c,d (101.64, 105.99) | 300.00 g,h (280.60, 319.40) |
|
| 3.02 f,g (1.75, 4.31) | 103.14 c,d (100.96, 105.31) | 335.67 e-h (316.27, 355.06) |
|
| 3.98 d-g (2.70, 5.26) | 104.14 c,d (101.97, 106.32) | 403.00 b,c (383.60, 422.40) |
|
| 4.23 c-g (2.95, 5.51) | 104.42 b-d (102.25, 106.60) | 387.30 b-d (367.90, 406.70) |
|
| 4.88 d-g (3.60, 6.16) | 105.14 b-d (102.96, 107.31) | 337.33 d-h (317.94, 356.73) |
|
| 3.98 d-g (3.08, 4.89) | 104.16 c,d (102.62, 105.70) | 409.20 b (395.50, 422.90) |
|
| 7.70 b,c (6.42, 8.98) | 108.35 b,c (106.17, 110.52) | 347.00 d-g (327.60, 366.40) |
|
| 4.34 d-g (3.61, 5.08) | 104.56 b-d (103.30, 105.82) | 364.42 c-e (353.22, 375.62) |
|
| 6.85 b-d (5.95, 7.76) | 107.39 b,c (105.85, 108.93) | 350.02 d-f (336.30, 363.73) |
|
| 9.01 b (7.73, 10.29) | 109.91 b (107.73, 112.08) | 300.00 g,h (280.60, 319.40) |
|
| 7.29 b-d (6.01, 8.57) | 107.87 b,c (105.69, 110.04) | 310.40 f-h (291.00, 329.80) |
|
| 6.45 b-e (5.17, 7.73) | 106.89 b-d (104.72, 109.07) | 345.67 d-g (326.27, 365.06) |
|
| 6.72 b-e (5.44, 8.00) | 107.21 b-d (105.03, 109.38) | 300.00 g,h (280.60, 319.40) |
|
| 48.97 a (47.69, 50.25) | 196.18 a (194.01, 198.36) | 482.00 a (462.60, 501.40) |
|
| 7.66 b,c (6.38, 8.94) | 108.31 b,c (106.14, 110.49) | 361.60 c-e (342.20, 381.00) |
|
| 4.88 c-g (3.60, 6.16) | 105.14 b-d (102.96, 107.31) | 383.83 b-e (364.44, 403.23) |
|
| 2.82 g (1.91, 3.72) | 102.90 d (101.37, 104.44) | 300.00 g,h (286.30, 313.70) |
|
| 6.08 b-f (4.80, 7.36) | 106.47 b-d (104.30, 108.65) | 371.67 b-e (352.27, 391.06) |
|
| 5.02 c-g (3.74, 6.30) | 105.28 b-d (103.11, 107.46) | 369.33 b-e (349.94, 388.73) |
|
| <0.0001 | <0.0001 | <0.0001 |
Values are means of triplicate measurement per number of sample (95% confidence interval for the mean). Means that do not share a letter are significantly different.
aWheat + Maltodextrin + Skimmed milk powder+Micronutrients; Millet + Soy; and Maize + Soy: Two (2) different brands.
bMaize + Soy + Peanut: Three (3) different brands.
All others were one (1) brand.
Fig 1(A) Viscosity of commercial complementary blends before dilution and (B) the viscosity of commercial complementary blends after dilution.
Fig 2The protein content of commercial complementary blends.
Fig 3Aflatoxin concentration of commercial complementary blends.